Drugs · acquisition-cost intelligence
SEREVENT DISKUS
salmeterol xinafoate· ingredient salmeterolSelective beta-2-adrenoreceptor agonists· SALMETEROL XINAFOATE 50 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$6.74
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other salmeterol products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| ADVAIR DISKUS | $1.33 | −$5.42 |
| ADVAIR DISKUS | $3.12 | −$3.62 |
| Fluticasone Propionate and Salmeterol HFA | $20.32 | +$13.58 |
| ADVAIR HFA | $22.72 | +$15.98 |
| AirDuo RespiClick | $110.30 | +$103.55 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.